CD274 and neoplasm: This assay permitted the inclusion of a standardized protocol in the determination of PD-L1 expression, measured as the percentage of tumour cells and infiltrating immune cells expressing PD-L1, and has shown, despite all previously reported limitations, good premises as a predictive biomarker.